Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Public ClinicalTrials.gov record NCT07284979. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Active- and Placebo-Controlled, Partially-Blinded Study to Compare the Efficacy and Safety of KAI-9531 Administered Once Weekly Versus Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to semaglutide SC once weekly and to placebo SC once weekly on percent change in body weight.
Study identification
- NCT ID
- NCT07284979
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,270 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 30, 2025 (Actual)
- Primary completion
- Mar 2028 (Estimated)
- Completion
- Apr 2028 (Estimated)
- Last update posted
- Oct 6, 2026
2025 – 2028
United States locations
- U.S. sites
- 28
- U.S. states
- 19
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kailera Clinical Site | Glendale | Arizona | 85308 | — |
| Kailera Clinical Site | Phoenix | Arizona | 85012 | — |
| Kailera Clinical Site | Little Rock | Arkansas | 72205 | — |
| Kailera Clinical Site | Northridge | California | 91325 | — |
| Kailera Clinical Site | Oceanside | California | 92058 | — |
| Kailera Clinical Site | Hamden | Connecticut | 06517 | — |
| Kailera Clinical Site | Stamford | Connecticut | 06905 | — |
| Kailera Clinical Site | Orange City | Florida | 32763 | — |
| Kailera Clinical Site | Albany | Georgia | 31707 | — |
| Kailera Clinical Site | Chicago | Illinois | 60640 | — |
| Kailera Clinical Site | Skokie | Illinois | 60077 | — |
| Kailera Clinical Site | Newton | Kansas | 67114 | — |
| Kailera Clinical Site | Shreveport | Louisiana | 71105 | — |
| Kailera Clinical Site | Farmington Hills | Michigan | 48334 | — |
| Kailera Clinical Site | Missoula | Montana | 59804 | — |
| Kailera Clinical Site | Las Vegas | Nevada | 89148 | — |
| Kailera Clinical Site | Albany | New York | 12203 | — |
| Kailera Clinical Site | Morehead City | North Carolina | 28557 | — |
| Kailera Clinical Site | Morrisville | North Carolina | 27560 | — |
| Kailera Clinical Site | Norman | Oklahoma | 73069 | — |
| Kailera Clinical Site | East Greenwich | Rhode Island | 02818 | — |
| Kailera Clinical Site | North Charleston | South Carolina | 29405 | — |
| Kailera Clinical Site | Spartanburg | South Carolina | 29303 | — |
| Kailera Clinical Site | Brownsville | Texas | 78526 | — |
| Kailera Clinical Site #1 | San Antonio | Texas | 78229 | — |
| Kailera Clinical Site #2 | San Antonio | Texas | 78229 | — |
| Kailera Clinical Site | Manassas | Virginia | 20110 | — |
| Kailera Clinical Site | Richmond | Virginia | 23236 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07284979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 6, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07284979 live on ClinicalTrials.gov.